Get the Stockscreener App
5.72
1.72%
-0.10
Pre-market:
5.61
-0.11
-1.92%
Lensar Inc stock is traded at $5.72, with a volume of 58,530.
It is down -1.72% in the last 24 hours and up +3.25% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
See More
Previous Close:
$5.82
Open:
$5.77
24h Volume:
58,530
Relative Volume:
0.51
Market Cap:
$69.24M
Revenue:
$57.70M
Net Income/Loss:
$11.98M
P/E Ratio:
-9.9548
EPS:
-0.5746
Net Cash Flow:
$-12.24M
1W Performance:
+2.14%
1M Performance:
+3.25%
6M Performance:
-50.35%
1Y Performance:
-54.24%
1-Day Range:
$5.59
$5.89
1-Week Range:
$5.50
$5.89
52-Week Range:
$5.06
$13.47
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
5.72 | 69.24M | 57.70M | 11.98M | -12.24M | -0.5746 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-26 | Upgrade | Lake Street | Hold → Buy |
| Mar-18-26 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
LENSAR (LNSR) Consolidates Near Support as Traders Eye Resistance at $6.11Box Spread - newsline.com
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
LENSAR Q1 earnings call highlights - MSN
(LNSR) Risk Channels and Responsive Allocation - Stock Traders Daily
LNSR Technical Analysis & ETF Price Forecast - Intellectia AI
LENSAR (LNSR) director Ellis granted 17,421 RSUs and reports holdings - Stock Titan
Lensar (LNSR) director receives 17,421 RSUs, reports 1.1M+ indirect shares - Stock Titan
LENSAR (LNSR) grants 13,066 RSUs to principal accounting officer - Stock Titan
LENSAR (LNSR) COO granted 34,843 RSUs in four-year vesting award - Stock Titan
LENSAR (LNSR) CEO receives 130,662 RSUs vesting over four years - Stock Titan
LENSAR (LNSR) director Aimee Weisner receives 17,421 RSUs as annual equity grant - Stock Titan
LENSAR (LNSR) director awarded 17,421 RSUs as annual stock compensation - Stock Titan
LENSAR (LNSR) director Gary Winer receives 17,421 RSU equity award - Stock Titan
LENSAR (LNSR) director receives 17,421 RSUs as annual equity award - Stock Titan
LENSAR, Inc. (LNSR) director receives 17,421 RSU equity grant - Stock Titan
LENSAR (LNSR) Interim CFO Michael A. Rossi files initial SEC Form 3 - Stock Titan
How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target - Yahoo Finance
Lensar Inc. Earnings Call Balances Recovery And Risk - The Globe and Mail
LENSAR Inc stock (US52633C1071): Q1 recurring revenue rose 9% - AD HOC NEWS
Lensar (LNSR) Q1 2026 Earnings Transcript - AOL.com
Lensar (LNSR) Q4 2025 Earnings Transcript - AOL.com
Lensar Reports First Quarter Fiscal 2026 Results; Management Highlights Strategic ProgressRevenue Inflection Point - newsline.com
Lensar (LNSR) Releases Q1 2026 Earnings Transcript: Key Insights for InvestorsGuidance Accuracy Score - The Legal Advocate
LENSAR Appoints Interim CFO, Accelerates Governance Timeline - The Globe and Mail
(LNSR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
LENSARAppoints Michael A. Rossi As Interim CFO Effective May 29, 2026 - TradingView
[8-K] LENSAR, Inc. Reports Material Event - Stock Titan
LENSAR, Inc. Announces Appointment of Michael A. Rossi as Interim Chief Financial Officer, Effective May 29, 2026 - marketscreener.com
LENSAR Inc stock (US52633C1071): Q1 2026 update and valuation snapshot after volatile Nasdaq trading - AD HOC NEWS
LNSR Earnings Overview 2026-05-28Growth Acceleration Report - thelegaladvocate.com
LENSAR (LNSR) Stock Edges Lower Amid Modest Selling Pressure — Key Levels in FocusQuote Data - newsline.com
Lensar Stock Rallies Into Memorial Day Break — Why Tuesday’s Open Matters - Bez Kabli
LNSR Earnings Overview 2026-05-22Crowd Stock Picks - Newser
LENSAR Inc. (LNSR) Gains 1.2% as Shares Test Key Resistance ZoneVolume Rate Change - The Legal Advocate
LENSAR (LNSR) Up +3.57% — 3 Reasons the Rally Could Continue 2026-05-21Zero Gamma Level - Newser
LENSAR Inc stock (US52633C1071): FDA clearance for ALLY lowers capital requirements for eye surgeons - AD HOC NEWS
LENSAR (LNSR) Gains +1.38% — Support Holds at $5.59 2026-05-20Dark Pool Prints - Newser
Liquidity Mapping Around (LNSR) Price Events - Stock Traders Daily
What LENSAR (LNSR)'s +1.62% Jump Means for Investors 2026-05-18Community Pattern Alerts - Newser
LENSAR stock (US52633C1071): eye-surgery specialist back in focus after Alcon deal collapse - AD HOC NEWS
LENSAR Inc stock (US52634T1034): laser eye surgery specialist in focus after latest business updates - AD HOC NEWS
LENSAR signals 2027 as really, really good year as it rebuilds distributor orders after Alcon deal termination - MSN
Q1 2026 LENSAR Inc Earnings Call Transcript - GuruFocus
Brandes Investment Partners (NASDAQ: LNSR) holds 1.03M shares, 8.48% - Stock Titan
Earnings call transcript: LENSAR Q1 2026: EPS Miss, Stock Rises on Revenue Stability - Investing.com Nigeria
[144] LENSAR, Inc. SEC Filing - Stock Titan
All News for LNSR : LENSAR - Zacks Investment Research
Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $10 - Moomoo
MSN Money - MSN
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):